26 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
of Apexigen’s third-party manufacturer to procure raw materials from third-party suppliers and potential exposure to supply chain issues impacting … delivery dates, quality, quantity and pricing of raw materials, including due to the COVID-19 pandemic, which may result in additional costs and delays
425
PYXS
Pyxis Oncology Inc
24 May 23
Business combination disclosure
7:05am
by such vendor and/or supplier during the applicable period) from which the Company or any Company Subsidiary ordered raw materials, components
8-K
EX-2.1
APGN
Apexigen Inc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
by such vendor and/or supplier during the applicable period) from which the Company or any Company Subsidiary ordered raw materials, components, supplies
424B3
pq403ubdf5 4z
10 Apr 23
Prospectus supplement
4:03pm
424B3
n80tjjy
10 Apr 23
Prospectus supplement
4:02pm
POS AM
l9llfh5e mhmx83pne10
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
hsaeh7tmlqkekne
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
np442tn zzct8uo5r
9 Sep 22
Prospectus supplement
4:40pm
424B3
q4exq
9 Sep 22
Prospectus supplement
4:38pm
424B3
eitkwvjddq
6 Jul 22
Prospectus supplement
4:18pm